Pantoprazole
Pantoprazole is a proton-pump inhibitor (PPI) approved by the FDA for the treatment and maintenance of erosive esophagitis associated with gastroesophageal reflux disease, as well as for pathological hypersecretory conditions such as Zollinger-Ellison syndrome. In both inpatient and outpatient settings, pantoprazole remains a common therapeutic agent due to a favorable safety profile and availability in both adult and pediatric formulations. Clinicians may also prescribe pantoprazole off-label for eradicating Helicobacter pylori, preventing NSAID-induced ulcers, and prophylaxis against stress ulcers in patients who are critically ill.
www.ncbi.nlm.nih.gov
Evrim Ağacı
